This is particularly beneficial for patients with digestive conditions or those who experience gastrointestinal intolerance to oral supplements
It is possible that CJC-1295 may also increase the risk of edema and joint discomfort due to higher water retention, similar to sermorelin
Notably, although plant metabolites such as berberine, emodin and curcumin have been shown in vitro to improve NAFLD symptoms by regulating hepatic lipid metabolism and inhibiting hepatocellular inflammation, they are categorized as pan-assay interference compounds (PAINS), which may generate false-positive results in vitro through non-specific mechanisms ( in vivo studies to exclude assay interference
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
However, the efficacy of nasal administration may differ compared to other methods, and individual responses may vary
Practical considerations include keeping the peptides in separate vials